Immunology Market, by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others), by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammat

Immunology Market, by Drug Class (Monoclonal Antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal Antibody (pAb), and Others), by Disease Indication (Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

The immune system is a collection of internal structures and processes that protects the body from potentially harmful foreign bodies and diseases. It recognizes and distinguishes diverse dangers such as bacteria, viruses, and parasites from the body's healthy tissues. When our immune system becomes weakened and loses its ability to recognize and eliminate aberrant cells, our bodies attack and damage their own tissues, resulting in diseases like cancer and autoimmune diseases. Immunotherapy is a treatment strategy that involves activating, strengthening, or suppressing the immune system in order to fight diseases.
There are 80 different forms of autoimmune illnesses, with rheumatoid arthritis, systemic lupus erythematosus (Lupus), juvenile rheumatoid arthritis, inflammatory bowel arthritis, and psoriatic arthritis being the most common. These autoimmune diseases affect different body organs such as joints, muscles, skin, red blood cells, blood vessels, connective tissues, and endocrine glands. Immunology drugs are one of the preferable choice of immunotherapy that is used by several oncologists as they provide long-lasting affect by activating the immune system to identify cancerous cells and kill them through the natural process & improve the quality of survival.
Market Dynamics
One of the primary factors driving the global immunology market expansion is the high frequency of autoimmune illnesses such as rheumatoid arthritis, systemic lupus erythematosus (Lupus), juvenile rheumatoid arthritis, inflammatory bowel arthritis, Psoriatic arthritis, and others. According to a research from the National Institutes of Health, up to 23.5 million Americans (almost 7% of the population) had an autoimmune disease in 2017, therefore increasing the patient pool which will ultimately boost the market.
Key features of the study:
This report provides in-depth analysis of the global immunology market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global immunology market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies.
Key companies covered as a part of this study include AbbVie Inc., Janssen Global Services, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Amgen Inc., Pfizer Inc., Novartis, Astellas, Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., UCB SA, and Allergan plc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global immunology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global immunology market
Detailed Segmentation:
Global Immunology Market, By Drug Class:
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
Global Immunology Market, By Disease Indication:
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
Global Immunology Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Immunology Market, By Region:
North America
By Drug Class
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
By Disease Indication
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
U.S.
Canada
Latin America
By Drug Class
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
By Disease Indication
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Drug Class
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
By Disease Indication
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Drug Class
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
By Disease Indication
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Drug Class
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
By Disease Indication
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country
GCC
Israel
Rest of Middle East
Africa
By Drug Class
Monoclonal Antibody (mAb)
Fusion Proteins
Immunosuppressants
Polyclonal Antibody (pAb)
Others
By Disease Indication
Rheumatoid Arthritis
Psoriatic Arthritis
Plaque Psoriasis
Ankylosing Spondylitis
Inflammatory Bowel Disease
Prophylaxis of Organ Rejection
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
AbbVie Inc.*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Janssen Global Services,
Johnson & Johnson
F. Hoffmann-La Roche Ltd.
Amgen Inc.
Pfizer Inc.
Novartis
Astellas
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp.
UCB SA
Allergan plc.
“*” marked represents similar segmentation in other categories in the respective section.